Pfizer, NYU Developing COVID-19 Vaccine With Hopeful September Release

Pfizer, NYU Developing COVID-19 Vaccine With Hopeful September Release

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the development of a coronavirus vaccine expected by September, using innovative mRNA technology. However, challenges exist as no RNA vaccine has been approved for human use. Pfizer and other groups are racing to develop a vaccine, but predicting the most effective one with minimal side effects remains uncertain.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What innovative method is being used to develop the coronavirus vaccine?

Developing a protein-based vaccine

Employing messenger RNA

Utilizing live attenuated virus

Using traditional virus inactivation

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why have RNA vaccines not been approved for human use yet?

They cause severe side effects in humans

They require complex storage conditions

They are too expensive to produce

They have only been effective in animal tests

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which company is mentioned as part of the race to develop a coronavirus vaccine?

Johnson & Johnson

Moderna

Pfizer

AstraZeneca

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What does Dr. Anthony Fauci warn about the coronavirus vaccines?

They are guaranteed to be safe

They will be available by next year

It's hard to predict their effectiveness and side effects

They will be distributed globally

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main challenge in predicting the success of a coronavirus vaccine?

The public's acceptance

The effectiveness and side effects

The speed of distribution

The cost of production